techgroup header image oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells

therapoid

  1. Home
  2. Technologies
  3. oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells
  4. Summary
Provided by: Open Therapeutics™ ; Research Institute Nationwide Children's Hospital
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
techgroup
Short Description:

Engineered oHSV lytically destroy cancer cells and stimulates the immune system to act against cancer cells.

Projects based on this Technology

Start New Project